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Dual roles of endogenous and 
exogenous galectin-1 in the control 
of testicular immunopathology
Cecilia V. Pérez1, Leticia G. Gómez1, Gisela S. Gualdoni1, Livia Lustig1, 
Gabriel A. Rabinovich2,3 & Vanesa A. Guazzone1
Galectin-1 (Gal-1), a proto-type member of galectin family, is highly expressed in immune privileged 
sites, including the testis. However, in spite of considerable progress the relevance of endogenous 
and exogenous Gal-1 in testis pathophysiology have not yet been explored. Here we evaluated 
the in vivo roles of Gal-1 in experimental autoimmune orchitis (EAO), a well-established model 
of autoimmune testicular inflammation associated with subfertility and infertility. A significant 
reduction in the incidence and severity of EAO was observed in mice genetically deficient in Gal-1 
(Lgals1−/−) versus wild-type (WT) mice. Testicular histopathology revealed the presence of multifocal 
testicular damage in WT mice characterized by an interstitial mononuclear cell infiltrate and different 
degrees of germ cell sloughing of seminiferous tubules. TUNEL assay and assessment of active 
caspase-3 expression, revealed the prevalence of apoptotic spermatocytes mainly localized in the 
adluminal compartment of seminiferous tubules in EAO mice. A significant increased number of 
TUNEL-positive germ cells was detected in EAO testis from WT compared with Lgals1−/− mice. In 
contrast, exogenous administration of recombinant Gal-1 to WT mice undergoing EAO attenuated 
the severity of the disease. Our results unveil a dual role of endogenous versus exogenous Gal-1 in 
the control of autoimmune testis inflammation.
Galectins a family of glycan-binding proteins are mainly defined by a common structural fold and a 
conserved carbohydrate recognition domain (CRD) of about 130 amino acids that recognizes N- and 
O-glycans expressing the disaccharide N-acetyllactosamine [Galβ (1–4)-GlcNAc or LacNAc]1. Galectin-1 
(Gal-1), a one-CRD member of the galectin family, is secreted to the extracellular milieu through a 
non-classical endoplasmic reticulum-Golgi-independent pathway2. Through its ability to recognize 
specific glycan structures, Gal-1 influences a variety of physiologic and pathologic processes includ-
ing pathogen recognition, immune cell signaling, activation and homeostasis, maintenance of placental 
immune privilege and suppression of autoimmune pathology3. Recently, Gal-1 has emerged as a novel 
hypoxia-regulated pro-angiogenic factor, which controls tumor progression4–6 and contributes to the 
pathogenesis of endometriosis and pre-eclampsia7,8. Interestingly, Gal-1 expression is regulated through-
out the spermatogenic process9. This lectin is expressed in Sertoli cells mainly at stages X–II of the 
spermatogenic cycle and is up-regulated during spermiation (stages VI–VIII) within the luminal pole of 
seminiferous epithelium, localized on apical stalks of Sertoli cells, on heads of mature spermatids and 
on bodies of residual cytoplasm. Following spermiation (stage VIII), Gal-1 expression is restored at the 
basal portion of Sertoli cells and progressively spread out through the whole cells as differentiation of 
germinal cells proceeded9. Moreover, a strong Gal-1 immunoreactivity is also detected in the cytoplasm 
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of Sertoli cells of human testis10,11. However, in spite of considerable progress, the function of Gal-1 in 
immune privilege and testis immunopathology has not yet been studied.
Immune privilege implies a special status conferred to some mammalian tissues, where allo- or 
self-antigens are well-tolerated and inflammation is circumvented12. The testis is considered an immune 
privileged site as it is able to tolerate self-antigens from developing germ cells that appear at puberty long 
after the establishment of immunocompetence, thus contributing to protect the highly specialized pro-
cess of spermatogenesis. Multiple mechanisms have been proposed to prevent autoimmune inflammation 
in the testis including: a) an immunological blood testis barrier (BTB), a structure that reduces the access 
of germ cell antigens to interstitial immune cells and the passage of antibodies from interstitium to tubu-
lar lumen; b) the secretion of numerous immunosuppressive factors mainly by macrophages, Sertoli, per-
itubular and Leydig cells resulting in a protective local microenvironment against immunologic attack; 
and c) the presence of regulatory CD4+ and CD8+ T cells (Tregs) which serve as local suppressors of 
effector T cell responses13. In addition, Sertoli cells can endocytose and degrade apoptotic germ cells 
and residual bodies, thus preventing potential autoimmune responses against spermatogenic cells14–16.
Early experimental data showed that testes can sustain foreign grafts for extended time periods with-
out evidence of rejection17. Moreover, allogenic testes ectopically transplanted under the kidney capsule 
resisted rejection in the absence of generalized immunosuppression18,19. More recently, co-implantation 
with Sertoli cells led to prolonged survival of allogeneic pancreatic islets in diabetic mice20,21. Moreover, 
Dal Secco et al. showed that Sertoli cells can suppress CD8+ T cell proliferation through PD-L1-inducing 
Treg cells22. However, in spite of its immune privileged status, the testis can orchestrate both innate and 
adaptive immunity and promote inflammatory responses to local and systemic infections. The delicate 
equilibrium between immune privilege and inflammation is modulated by critical cytokines that con-
tribute to ignite immunosuppressive or inflammatory circuits in local or systemic microenvironments. 
Disruption of these immunoregulatory circuits may lead to the development of autoimmune orchitis and 
impairment of normal fertility23.
Experimental autoimmune orchitis (EAO) is a useful model to study organ-specific autoimmunity 
and chronic testicular inflammation. Current information on the mechanisms underlying testicular 
pathology and potential treatments stems from the pioneering work by Tung et al.24 in mice and the 
subsequent establishment of the EAO model in rats13,25. In both models testicular histopathology is char-
acterized by interstitial mononuclear cell infiltrates and damage of seminiferous tubules that exhibit germ 
cell apoptosis and severe cell sloughing (mainly spermatocytes and spermatids). Progression of EAO is 
associated with fibrosis, testicular atrophy and infertility26.
Here we aimed to investigate the pathophysiologic relevance of endogenous and exogenous Gal-1 in 
testicular immune privilege and pathology using the EAO model.
Materials and Methods
Animals. Six- to eight-week-old male C57BL/6J (wild-type, WT) mice were purchased from the ani-
mal facilities at the Facultad de Ciencias Veterinarias (Universidad Nacional de La Plata, Argentina). 
Mice with equivalent genetic background and mutation in the Gal-1-encoding gene (Lgals1−/−) were 
originally supplied by F. Poirier (Jacques Monod Institut, Paris). Animals were kept at 22 °C with a 14 h 
light-10 h dark schedule and fed standard food pellets and water ad libitum. All experimental protocols 
were performed in accordance with approved guidelines from the Universidad de Buenos Aires (UBA) 
and the Instituto de Biología y Medicina Experimental (IBYME, CONICET).
Induction of EAO. Lgals1−/− and WT mice were actively immunized with mouse testicular homogen-
ate (TH) (experimental group; E) as previously described27. Briefly, 300 mg of dry weight TH in 1.5 ml of 
distilled water was emulsified with an equal volume of Freund’s adjuvant prepared by adding 100 mg of 
Mycobacterium tuberculosis (H37Ra, Difco Laboratories, Detroit, Michigan, USA) to incomplete Freund’s 
adjuvant (Sigma-Aldrich, St. Louis, MO, USA). Each animal received 0.1 ml of the emulsion distributed 
in one hind footpad, base of tail and hind flank by s.c. injection. In addition, each animal received 0.4 μ g 
of Pertussis toxin (Ptx; Sigma-Aldrich) dissolved in 0.1 ml of saline solution following by an additional 
dose 24 h later by i.p. injection. Control (C) mice received adjuvants and Ptx, but no TH following 
the same scheme. Normal (N) untreated mice were also studied. All animals were killed 30 days after 
immunization. Testes were removed and processed for different experimental settings as detailed below.
Histopathology. Histopathology of the testis and epididymis was evaluated in paraffin-embedded 
Bouin’s-fixed sections obtained from three different levels and stained with hematoxylin-eosin or 
PAS-hematoxylin. To quantify EAO incidence and severity, we used an established score28. Briefly, EAO 
score was graded by evaluation of seminiferous tubules, straight tubules, epididymis and vas deferens 
inflammation, seminiferous tubules germ cell loss, and epididymis and vas deferens sperm depletion. 
Moreover, testis and epididymal inflammation scores were determined as follows: 1, focal; 5, diffuse 
inflammation with necrosis; and 2–4, range of incremental inflammation. Aspermatogenesis: 1–10 rep-
resent the percentage of seminiferous tubules with reduction or absence of germ cells. Maximum EAO 
score is 31. Animals with a score under or equal to 5 were considered free of orchitis. Quantification 
of blood vessels was performed by light microscopy with a 10x ocular and a 40x objective. Data were 
obtained from 6 mice/group. Two sections/mouse were counted and results were expressed as the 
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number of vessels per 100 seminiferous tubules cross-sections. No distinction was drawn between arte-
rioles, venules and capillaries.
Immunohistochemistry. Immunoperoxidase staining was performed using the avidin-biotin sys-
tem (ABC Vectastain Kit, Vector Lab., Burlingame, CA, USA) to detect Gal-1 or active caspase-3. 
Deparaffinized and hydrated sections were subjected to antigen retrieval by microwaving (370 W) in 
0.01 M citrate buffer, pH 5.5 for 15 min. Endogenous peroxidase activity was blocked by treatment with 
0.3% H2O2 in methanol for 30 min. Sections were washed in phosphate buffered saline (PBS) and incu-
bated with 5% skim milk, 0.01% Triton X-100 to detect Gal-1 or with 0.1% saponin in PBS 0.01% Triton 
X-100 to detect active caspase 3. Sections were then incubated with avidin/biotin blocking solution 
(Vector Lab.). After incubation with a rabbit anti-Gal-1 polyclonal antibody (1:50) as described [4] or 
anti-human/mouse active caspase-3 antibody (10 μ g/mL) (R&D Systems, Minneapolis, MN, USA) for 48 h 
at 4 °C in a humidified chamber, sections were incubated with biotinylated anti-rabbit IgG (1:375, Vector 
Lab.). Then the reaction was amplified using ABC Vectastain kit and the 3-3’diaminobenzidine-H2O2 
(DAB Substrate Kit, Vector Lab.) was used as peroxidase substrate. Sections were counterstained with 
hematoxylin. Negative controls were obtained by incubating sections with the corresponding IgG iso-
types instead of primary antibodies.
Western blot. Expression of Gal-1 protein was evaluated in the seminiferous tubule and interstitial cell 
(IC) fractions. Briefly, testes were decapsulated and placed on a Petri dish containing PBS. Seminiferous 
tubules (ST) were mechanically separated from IC with needles and filtered through a fine stainless steel 
screen. The cell suspension, containing IC, was centrifuged at 300 × g for 10 min. Both fractions were 
homogenized in ice-cold lysis buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 
0.5% sodium desoxycholate, 1% NP-40] with protease inhibitors (2 mM phenylmethylsulphonyl fluoride, 
10 μ g⁄ml leupeptin, 10 μ g⁄ml pepstatin A and 10 μ g⁄ml aprotinin; Sigma-Aldrich). Homogenates were 
centrifuged at 13,500 g for 30 min at 4 °C. Proteins were measured in supernatants using the Bio-Rad DC 
Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA). Equal amounts of protein (25 μ g from the ST 
fraction or 100 μ g from the IC fraction) were resolved in a 15% SDS-polyacrylamide gel electrophoresis. 
Proteins were electroblotted at 150 V for 60 min to PVDF membranes (Bio-Rad Laboratories). Transfer 
was monitored by Ponceau S staining. Membranes were blocked with 5% non-fat dry milk in TBS con-
taining 0.1% Tween 20 for 1 h. Blots were probed overnight with a rabbit anti-Gal-1 polyclonal antibody 
(1:5000) generated and used as described [4] followed by anti-actin (1:3000; Sigma-Aldrich) polyclonal 
antibody. Blots were washed and incubated with a biotinylated goat anti-rabbit IgG (1:6000; Vector Lab.) 
followed by streptavidin-horseradish peroxidase conjugates (Chemicon International Inc, Millipore Co., 
Billerica, MA, USA). Proteins were visualized by enhanced chemiluminescence. Images were captured 
using the GeneSnap software (7.08.01 version) and were analyzed with Gene Tools software (4.01.02 
version) from SynGene (Synoptics Ltd, Frederick, MD, USA).
TUNEL assay. Deparaffinized and hydrated sections from testes were irradiated in a microwave oven 
(370 W for 5 min) in 10 mM sodium citrate buffer, pH 6 and permeabilized with 0.1% Triton X-100 in 
0.1% sodium citrate for 5 min at 4 °C. Non-specific labeling was prevented by incubating the prepara-
tions with blocking solution (5% blocking reagent; Roche Molecular Biochemicals GmbH, Mannheim, 
Germany, in 150 mM NaCl and 100 mM maleic acid, pH 7.5) for 30 min at room temperature. The 
apoptotic DNA was 3´-end labeled with digoxigenin-11-dideoxyuridine triphosphate (Dig-11-ddUTP; 
Roche) by the TdT reaction (0.17 U/ml TdT; Roche) in TdT buffer for 1 h at 37 °C. In negative controls, 
TdT enzyme was replaced with the same volume of distilled water. Preparations were then incubated with 
blocking solution (2% blocking reagent in 150 mM NaCl and 100 mM maleic acid, pH 7.5) for 30 min at 
room temperature, followed by the detection of the Dig-11-ddUTP with alkaline phosphatase-conjugated 
anti-digoxigenin antibody (1:2000; Roche) for 2 h at room temperature. Sections were rinsed and equil-
ibrated in alkaline phosphatase buffer (100 mM Tris–HCl, 100 mM NaCl, 50 mM MgSO4, pH 9.5) con-
taining 1 mM levamisole (Sigma-Aldrich). Then, alkaline phosphatase substrates, nitroblue tetrazolium 
and 5-bromo-4-chloro-3-indolyl-phosphate (NBT/BCIP; Roche) were added for 60 min. The reaction 
was stopped by washing preparations with TE buffer (10 m MTris–HCl, 1 mM EDTA, pH 8.0). Sections 
were counterstained with eosin, dehydrated and mounted. Finally, TUNEL-positive cells were quantified 
in 100 tubules per testis.
Experimental design: administration of rGal-1. Production and purification of recombinant 
Gal-1 (rGal-1) was performed as outlined previously29. Mice (WT) from E group were injected i.p. with 
rGal-1 (2.5 mg/kg) or saline solution (vehicle). Treatment started 21 days after immunization and contin-
ued throughout the experiment with intervals of 2 days. Mice were killed at 30 days after immunization. 
Testes were removed and processed for histopathology.
Statistical analysis. Comparisons between groups were assessed by the non-parametric 
Mann-Withney U test or Kruskal–Wallis One-Way ANOVA. P values less than 0.05 were considered 
significant.
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Results
Histopathologic features of the EAO mouse model. To understand the relevance of endogenous 
Gal-1 in testicular immunopathology, we first sought to establish an EAO model in C57BL/6J mice. 
Notably, 95.5% of WT mice from experimental group sacrificed 30 days after the immunization devel-
oped autoimmune orchitis with different degrees of severity. Testicular pathology was characterized by an 
interstitial inflammatory cell infiltrate and damage of the germinal epithelium (Fig. 1C,D). Immune cell 
infiltrate was mostly confined to the subalbuginea interstitium and extended through the whole organ 
in severe EAO. Seminiferous tubules showed the presence of degenerating spermatocytes, multinucleated 
germ cells and different degrees of germ cell sloughing in the lumen. In severe EAO only spermatogonia, 
few spermatocytes and Sertoli cells remained attached to the tubular wall. Vacuolization of Sertoli cell 
cytoplasm was frequently observed. In the epididymis interstitial immune cell infiltrates (F) and the 
presence of immature germ cells in tubular lumen were frequently detected in EAO mice. Occasionally, 
immune cell infiltrates were observed within damaged seminiferous tubules. No pathological alterations 
were found in the testis and epididymis of normal and control groups (Fig. 1A,B,E).
Assessment of the number of testicular vessels revealed a significant increase of these structures in 
the testicular interstitium of mice with orchitis. Interestingly, the extent of vascularization was associ-
ated with the degree of histopathologic damage (Normal (N) score: 129.90 ± 9.90, Control (C) score: 
113.00 ± 5.35, Experimental (E) with mild EAO score: 164.50 ± 8.86a,b, E with severe EAO score: 
196.30 ± 6.31c,d. a,bp < 0.05 vs N and C, c,dp < 0.001 vs N and C).
Regulated expression of Gal-1 in inflamed testis. To analyze the regulated expression of Gal-1 
in inflamed testis, sections from normal and EAO mice were processed by immunohistochemistry. In 
testicular interstitium from normal mice, Gal-1 was detected in Leydig cells, as well as in the seminif-
erous tubules, in Sertoli cell cytoplasm and germ cells. A high Gal-1 expression was detected in the 
entire cytoplasm of Sertoli cells from the basal to the apical area. A milder staining was observed in 
differentiating germ cells and spermatozoa. A similar localization and intensity of Gal-1 expression was 
detected in normal and EAO mice. No staining was observed in sections incubated with IgG isotype 
control antibody instead of primary antibody (Fig.  2). No changes in Gal-1 expression were detected 
by Western blot in interstitial cells (Fig.  3) and in seminiferous tubule (Fig.  4) fractions from normal, 
control and EAO group.
Lack of Gal-1 reduces the incidence and severity of EAO. The role of endogenous Gal-1 was 
studied in vivo in the EAO model. EAO was induced in male WT and Lgals1−/− mice as described in 
Materials and Methods. Whereas 93.1% of WT mice developed orchitis, a significant decrease in EAO 
incidence (61%) was observed in mice devoid of Gal-1. Interestingly, Lgals1−/− mice exhibited a signif-
icant reduction of EAO severity compared to their WT counterpart (Fig. 5A), showing focal testicular 
damage with mild cell infiltrate. Moreover, a significant lower percentage of seminiferous tubules with 
germ cell sloughing was also observed in Lgals1−/− mice (Fig. 5C). Interestingly, a trend toward a reduc-
tion of testis inflammation was also observed in Lgals1−/− mice, although these data were not found 
to reach statistical significance (Fig. 5B). Of note, WT and Lgals1−/− mice from control group did not 
develop orchitis (Fig.  5A). Thus, in contrast to the higher pathology observed in the context of Gal-1 
deficiency in other experimental autoimmune models including experimental autoimmune encephalo-
myelitis (EAE)30 and collagen-induced arthritis (CIA)31, EAO pathology was found to be less severe in 
Lgals1−/− compared to WT mice, suggesting context-dependent Gal-1-mediated regulation of autoim-
mune pathology.
Impact of endogenous Gal-1 on germ cell apoptosis. To examine the mechanisms underlying 
Gal-1 control of EAO severity, we next evaluated the impact of endogenous Gal-1 in germ cell apoptosis. 
For this, we studied the expression of the active form of caspase-3 and quantified the number of apop-
totic germ cells using an in situ TUNEL assay. We found that, spermatocytes from testis of mice with 
EAO were immunoreactive for caspase-3 (Fig. 6A) and positive for TUNEL assay (Fig. 6B). However, the 
number of apoptotic germ cells per seminiferous tubule in EAO WT mice was significantly higher than 
control and normal WT as well as experimental, control and normal Lgals1−/− groups (Fig. 6C). Of note, 
data from Lgals1−/− mice were comparable among experimental, control and normal groups (Fig. 6C).
Administration of exogenous rGal-1 reduces the severity of EAO. Based on the 
immune-inhibitory activity of exogenous rGal-1 in different models of autoimmune pathology30,32–35, we 
evaluated the effects of rGal-1 administration in WT mice during the course of EAO. Notably, injection 
of rGal-1 starting 21 days after mice immunization significantly reduced severity of EAO. Interestingly, 
testis inflammation and seminiferous tubule germ cell loss were both reduced in mice treated with rGal-1 
(Fig. 7). TUNEL assay revealed that only germ cells underwent apoptosis (Fig. 8A). Quantitative assess-
ment of TUNEL-positive cells revealed that administration of rGal-1 in WT mice undergoing orchitis 
reduced the number of apoptotic cells compared with vehicle-treated mice. (Figure  8B) Although we 
could not observe TUNEL-positive infiltrating immune cells, we cannot rule out an immune inhibitory 
mechanism mediated by T cell apoptosis in associated secondary lymphoid organs as demonstrated in 
other experimental models30,32–34.
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Thus, exogenous Gal-1 suppresses disease severity and inflammation and protected germ cells from 
inflammation-induced apoptosis. Collectively, these results highlight the dual and paradoxical roles of 
endogenous versus exogenous Gal-1 in the control of testicular immunopathology.
Figure 1. Testicular and epididymal histopathology. EAO was induced in WT (C57BL/6J) mice by 
immunization with testicular antigens and adjuvants. Testis (C and D) and epididymis (F) sections from 
the experimental group sacrificed 30 days after immunization exhibited an interstitial inflammatory cell 
infiltrate. Severe testicular damage was characterized by germ cell sloughing of the seminiferous tubules. 
Note the severe tubular atrophy showing decreased diameter of seminiferous tubules in experimental group. 
Testis (A and B) and epididymis (E) section from control group show normal histological features. H&E.
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Figure 2. Immunohistochemistry of Gal-1 expression in mouse testis sections. Photomicrographs of 
paraffin-embedded sections of normal (B) and experimental (C) adult testes immunostained with Gal-1 
antibody. Strong Gal-1 immunoreactivity can be observed within the seminiferous tubules associated with 
both Sertoli cells (arrow) and differentiating germ cells and also in Leydig cells (arrowhead) located in the 
interstitial spaces. Omission of primary anti-Gal-1 antibody was used as a negative control (A).
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Discussion
Compelling evidence on the immunoregulatory activity of Gal-1 and its abundant expression in immune 
privileged tissues including placenta, ovary and testis3, suggested that this endogenous lectin could play 
a critical role in the homeostatic control of immune privilege and inflammation in these tissues. We 
undertook this study to examine the regulated expression of Gal-1 in normal and inflamed testis and its 
ability to control testicular pathology.
Previous work documented the regulated expression of Gal-1 in rat testicular somatic and germ cells 
under physiologic conditions9. These early studies hypothesized that Gal-1 might confer immune privi-
lege to the testis by providing Sertoli cells with a mechanism to selectively eliminate infiltrating T lym-
phocytes. Seeking to understand the role of endogenous Gal-1 in testis homeostasis and inflammation, 
Figure 3. Expression of Gal-1 by interstitial cells of normal (N), control (C) and experimental (E) 
mice was analyzed by Western blot. The blots were cropped, and the full-length blots are presented in 
the supplementary information (Fig. S1 online). No changes in Gal-1 expression were observed between 
different groups. Each bar represents the mean ± SEM of 6 animals.
Figure 4. Expression of Gal-1 by seminiferous tubules of normal (N), control (C) and experimental 
(E) mice was analyzed by Western blot. The blots were cropped, and the full-length blots are presented 
in the Supplementary Information (Fig. S2 online). No changes in Gal-1 expression were observed among 
different groups. Each bar represents the mean ± SEM of 6 animals.
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Figure 5. Impact of endogenous Gal-1 in EAO incidence and severity. A- A significant decrease in 
EAO incidence (%) and reduced severity of the disease was observed in Lgals1−/− versus WT mice. EAO 
score from WT, Lgals1−/− experimental (E) group and control (C) group mice assessed by evaluation of 
seminiferous tubules, straight tubules, epididymis and vas deferens, germ cell loss, inflammation and sperm 
depletion. Animals with a score below or equal to 5 (…) were considered free of orchitis. B- Inflammation 
represents the degree of cellular infiltrate in the testicular interstitium and surrounding straight tubules. 
%: percentage of inflammation. Animals with an inflammation value equal to 0 were considered without 
inflammation. C- Aspermatogenesis represents the percentage of seminiferous tubules with reduction or 
absence of germ cells. Horizontal lines represent the mean value. Each symbol represents a single mouse. 
Values with different letter superscripts differ significantly (p < 0.05).
www.nature.com/scientificreports/
9Scientific RepoRts | 5:12259 | DOi: 10.1038/srep12259
Figure 6. Impact of endogenous Gal-1 on germ cell apoptosis during the course of EAO. Testes from 
experimental (E), control (C) or normal (N) WT and Lgals1−/− group mice were removed at 30 days 
after immunization, paraffin-embedded, and processed for caspase-3 expression and in situ TUNEL 
assay. A- Representative microphotograph (right picture) shows expression of active caspase-3 protein by 
immunoperoxidase staining in testis section from EAO WT mice group. Spermatocytes are immunoreactive 
for caspase-3. Omission of primary antibody shows negative staining in left picture. B- Representative 
microphotographs of TUNEL assay performed in EAO testis sections from WT (right picture) and Lgals1−/− 
(left picture) mice stained with eosin. TUNEL-positive cells are stained in blue. C- Quantitative assessment 
of TUNEL-positive cell number per 100 tubules per testis evaluated in a blinded fashion in each group. 
Horizontal lines represent the mean value and each symbol represents a single mouse. Values with different 
letter superscript differ significantly (p < 0.05).
www.nature.com/scientificreports/
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we assessed the expression and localization of Gal-1 in normal versus inflamed testis and evaluated the 
ability of WT and Lgals1−/− mice to develop autoimmune orchitis after active immunization with sperm 
antigens and adjuvants.
First, we confirmed that Gal-1 was expressed by Sertoli, Leydig and germ cells of adult mice as it has 
been previously demonstrated in rat, human and mice testis9,11,36. In Sertoli cells, Gal-1 mRNA and pro-
tein expression was found to be differentially regulated during spermatogenesis, suggesting that the Gal-1 
function in the adult seminiferous epithelium could depend on its cellular and subcellular distribution 
at different stages of the spermatogenic cycle36. Interestingly, we found comparable expression levels of 
Figure 7. Impact of exogenous Gal-1 in testicular immunopathology. A- Administration of rGal-1 
reduces the severity of EAO. EAO score of mice immunized with TH and adjuvants and injected with 
saline solution (vehicle) or rGal-1. Score evaluated seminiferous tubules, straight tubules, epididymis and 
vas deferens and includes germ cell loss, inflammation and sperm depletion. Animals with a score below or 
equal to 5 (…) were considered free of orchitis. B- Inflammation represents the degree of cellular infiltrates 
in the testicular interstitium and surrounding straight tubules. %: percentage of inflammation. Animals 
with an inflammation value equal to 0 were considered to be devoid of inflammation. C- Aspermatogenesis 
represents the percentage of seminiferous tubules with reduction or absence of germ cells. Horizontal lines 
represent media value. Each symbol represents a single mouse. (ap < 0.05 vs vehicle).
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Figure 8. Impact of exogenous Gal-1 on germ cell apoptosis. Testes from mice immunized with TH 
and adjuvant and injected with saline solution (vehicle) or recombinant Gal-1 (rGal-1) were removed, 
paraffin-embedded, and processed by in situ TUNEL assay. A- Representative microphotographs of TUNEL 
assay performed in EAO testis sections from mice treated with vehicle (A and C) or rGal-1 (B y D) and 
counterstained with eosin. TUNEL-positive cells are stained in blue. B- Quantitative assessment of TUNEL-
positive cell number in 100 tubules per testis evaluated in a blinded fashion in each group. Each symbol 
represents a single mouse. (p = 0.05).
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Gal-1 in normal and EAO mice suggesting that testis inflammation was not associated with an upreg-
ulation of Gal-1 expression. This result also differs from data reported in other autoimmune models of 
inflammation including CIA31 and EAE29,37 where substantial upregulation of Gal-1 was observed during 
the peak of resolution of autoimmune pathology.
Through binding and cross-linking specific cell surface glycans, Gal-1 functions as a homeostatic 
immune inhibitory signal that blunts pathogenic Th1 and Th17 responses30, favors the differentiation of 
FoxP3+ Treg cells38,39 and instructs dendritic cells to become tolerogenic37. These glycosylation-dependent 
functions account for the capacity of this lectin to dampen inflammation in autoimmune and chronic 
inflammatory disorders and to favor immune escape in different types of tumors3.
Based on the known immunosuppressive activities of Gal-1, we hypothesized that mice deficient in 
Gal-1 would develop more severe autoimmune orchitis compared to WT mice. Surprisingly, the inci-
dence and severity of EAO were lower in Lgals1−/− versus WT mice. This effect contrasted with the well 
established role of endogenous Gal-1 in restraining chronic inflammation in other models including 
EAE30 and CIA31, suggesting that the impact of endogenous Gal-1 in autoimmune inflammation may 
be context-dependent and/or that Gal-1 regulation of germ cell fate may prevail over the effects on 
T-cell dependent inflammation. Thus, endogenous Gal-1 may act either by increasing the inflammatory 
response or by inducing germ cell apoptosis.
Similar to our findings, Bischoff et al. observed that mice lacking Gal-1 developed a reduced inflam-
matory response mediated by glial cells in an experimental model of epileptic seizures40. Furthermore, 
Iqbal et al. showed different effects of this lectin in a mouse carrageenan paw edema model in which the 
inflammatory response presents an acute and a delayed phase41. In Lgals1−/− mice, the acute phase fol-
lowed a similar inflammatory profile compared to WT mice; however, a blunted response was observed for 
the second phase with significantly lower edema values and decreased immune cell number. Interestingly, 
the same authors31 reported a critical inhibitory role for endogenous Gal-1 during the development of 
chronic inflammation in the CIA model, suggesting that Gal-1 could play different roles whether it acts 
early or late during the course of acute or chronic inflammation. Moreover, these responses could be 
influenced by cellular and molecular networks operating in inflammatory and tissue microenvironments, 
including other immune-inhibitory pathways (e.g. PD-1/PD-L1 axis, Fas/Fas ligand pathway or secretion 
of immunosuppressive TGF-β or IL-10) which may act in concert to regulate tissue homeostasis. Of note, 
we could find no significant differences in the frequency of CD8+ T cells, CD11b+ macrophages and 
FoxP3+ regulatory T cells among different experimental groups (data not shown) suggesting that, in this 
particular experimental model, a direct pro-apoptotic effect on germ cells prevails over other regulatory 
or tolerogenic circuits. Although this is the first study demonstrating the effects of endogenous versus 
exogenous Gal-1 in regulating testicular immunopathology, further work is warranted at elucidating in 
depth the molecular mechanisms underlying these biological effects.
An extensively documented function of galectins is the control of immune and epithelial cell sur-
vival42,43. Whereas some galectins display pro-apoptotic activity, others function by protecting cells 
from common pro-apoptotic stimuli. Interestingly, exogenous galectins can trigger pro-apoptotic or 
anti-apoptotic events through binding to cell surface glycoproteins, whereas intracellular galectins con-
trol cell fate through interaction with endogenous signaling pathways44. Sensitivity of immune cells to 
Gal-1-induced cell death has been shown to be regulated by the glycosylation state of the cells and 
involves Fas-dependent or -independent pathways30,43,45,46.
Regarding the impact of Gal-1 on non-immune cells, Bischoff et al. reported a selective pro-apoptotic 
role of Gal-1 toward a subpopulation of forebrain neurons in an experimental model of epileptic seizures 
induced by pilocarpine injection in adult mice40. Moreover, Muglia and colleagues showed that endoge-
nous Gal-1 regulates small intestine villi length through mechanisms involving modulation of epithelial 
cell death43. Furthermore, in vitro studies showed that Gal-1 induces apoptosis of rat testis Leydig cells 
through interactions with extracellular matrix proteins47. Our results demonstrate that Gal-1 acts by 
inducing apoptosis of germ cells. A significant increase of TUNEL-positive germ cells was detectable in 
the testis of WT compared to Lgals1−/− mice or to normal untreated mice. Thus, Gal-1-induced germ cell 
apoptosis may account for the augmented susceptibility and severity of orchitis in WT versus Lgals1−/− 
mice. However, we cannot rule out the possibility that other Gal-1-mediated functions may contribute 
to this effect. Notably Gal-1 also plays a relevant role in angiogenesis by controlling endothelial cell 
signaling via non-canonical activation of vascular endothelial growth factor receptors (VEGFRs)48,49. 
In this regard, we observed an increased number of testicular blood vessels in EAO lesions, which was 
associated with the severity of the disease and was lower in Lgals1−/− mice versus WT mice with the 
same EAO score (Supplementary Fig. S3 online).
Nevertheless, administration of exogenous rGal-1 suppressed the clinical signs of EAO and damp-
ened testicular inflammation. This inhibitory effect followed the same anti-inflammatory pattern shown 
for other models of autoimmune inflammation, including CIA, EAE, experimental autoimmune uveitis 
and diabetes30,32,34,35, supporting its therapeutic use for the treatment of autoimmune testicular 
inflammation.
In conclusion, our study unveils the dual roles of endogenous versus exogenous Gal-1 in the control 
of testicular immunopathology. Moreover, our findings highlight the contribution of Gal-1 to germ cell 
apoptosis and suggest a note of caution regarding the proposed function of Gal-1 in the regulation of 
www.nature.com/scientificreports/
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testicular immune privilege. Finally, our studies validate the relevance of Gal-1 as a therapeutic agent for 
the treatment of testicular immunopathology.
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